参考文献/References:
[1] Walker MD, Green SB, Byar DP, et al. Randomized compa-
rison of radiotherapy and nitrosoureas for the treatment of
malignant glioma after surgery [J]. N Engl J Med, 1980, 303
(23): 1323-1329.
[2] Scholtyssek F, Zwiener I, Schlamann A, et al. Reirradiation
in progressive high-grade gliomas: outcome, role of concur-
rent chemotherapy, prognostic factors and validation of a
new-prognostic score with an independent patient cohort
[J]. Radiat Oncol, 2013, 8: 161.
[3] Chang L, Su J, Jia ZX, et al. Treating malignant glioma in
Chinese patients: update on temozolomide [J]. Onco Targets
Ther, 2014, 7: 235-244.
[4] Siega T. Which drug or drug delivery system can change cli-
nical practice for brain tumor therapy [J]? Neuro Oncology,
2013, 15(6): 656-669.
[5] 李远强，张 坤，孙丽丹，等. 肿瘤干细胞靶向给药系统的
研究[J]. 湖南医学，2017, 28（2）：260-262.
[6] Chen J, Xu ZY, Wang F. Association between DNA methy-
lation and multidrug resistance in human glioma SHG-44
cells [J]. Mol Med Rep, 2015, 3(2): 43-52.
[7] Noack A, Noack S, Hoffmann A, et al. Drug-induced traf-
ficking of p-glycoprotein in human brain capillary endothe-
lial cells as demonstrated by exposure to mitomycin C [J].
PLoS One, 2014, 9(2): e88154.
[8] Seebacher NA, Richardson DR, Jansson PJ. Glucose modu-
lation induces reactive oxygen species and increases
P-glycoprotein-mediated multidrug resistance to chemo-
therapeutics [J]. Br J Pharmacol, 2015, 172(10): 2557-
2572.
[9] Tivnan A, Zakaria Z, O'Leary C, et al. Inhibition of multi-
drug resistance protein 1 (MRP1) improves chemotherapy
drug response in primary and recurrent glioblastoma multi-
forme [J]. Front Neurosci, 2015, 9: 218.
[10] Tang SW, Bai C, Yang PY, et al. 14-3-3ε boosts bleomy-
cin-induced dna damage response by inhibiting the drug-
resistant activity of MVP [J]. J Proteome Res, 2013, 12(6):
2511-2524.
[11] L?tsch D, Steiner E, Holzmann K, et al. Major vault protein
supports glioblastoma survival and migration by upregula-
ting the EGFR/PI3K signalling axis [J]. Oncotarget, 2013, 4
(11): 1904-1918.
[12] El-Awady R, Saleh E, Hashim A, et al. The role of eukaryo-
tic and prokaryotic ABC transporter family in failure of
chemotherapy [J]. Front Pharmacol, 2017, 7: 535.
[13] Zhu DH, Tu M, Zeng B, et al. Up-regulation of miR-497
confers resistance to temozolomide in human glioma cells by
targeting mTOR/Bcl-2 [J]. Cancer Med, 2017, 6(2): 452-
462.
[14] Das CM, Aguilera D, Vasqucz H, et al. Valpreic acid
induces p21and topoisomerase-II(alpha/beta) expression
and synergistically enhances etoposide cytotoxicity in
human glioblastoma cell lines [J]. J Neurooncol, 2007, 85
(2): 159-170.
[15] Gumulec J, Raudenska M, Adam V, et al. Metallothionein-
immunohistochemical cancer biomarker: a meta-analysis
[J]. Plos One, 2014, 9(1): e85346.
[16] Qin LS, Jia PF, Zhang ZQ, et al. ROS-p53-cyclophilin-D
signaling mediates salinomycin-induced glioma cell
necrosis [J]. J Exp Clin Cancer Res, 2015, 34: 57.
[17] Colla R, Izzotti A, Ciucis CD, et al. Glutathione-mediated
antioxidant response and aerobic metabolism: two crucial
factors involved in determining the multi-drug resistance of
high-risk neuroblastoma [J]. Oncotarget, 2016, 43(7):
70715-70737.
[18] Abdel-Fattah R, Xiao A, Bomgardner D, et al. Differential
expression of HOX genes in neoplastic and non-neoplastic
human astrocytes [J]. J Pathol, 2006, 209: 15-24.
[19] Lamb KL, Liu Y, Ishiguro K, et al. Tumor-associated
mutations in O6-Methylguanine DNA-methyltransferase
(MGMT) reduce dna repair functionality [J]. Mol Carcinog,
2014, 53(3): 201-210.
[20] Yang QC, Wang YH, Lin Y, et al. Expression of 06-
methylguanine DNA methyltransferase (MGMT) and its
clinical significance in gastroenteropancreatic neuroendo-
crine neoplasm [J]. Int J Clin Exp Pathol, 2014, 7(7): 4204-
4212.
[21] Zhao H, Thienpont B, Yesilyurt BT, et al. Mismatch repair
deficiency endows tumors with a unique mutation signature
and sensitivity to DNA double-strand breaks [J]. Elife,
2014, 3: e02725.
[22] Schonberg DL, Lubelski D, Miller TE, et al. Brain tumor
stem cells: molecular characteristics and their impact on
therapy [J]. Mol Aspects Med, 2014, 39: 82-101.
[23] Liu H G, Lv L, Yang K. Chemotherapy targeting cancer stem
cells [J]. Am J Cancer Res, 2015, 5(3): 880-893.
[24] Tobias AL, Thaci B, Auffinger B, et al. The timing of neural
stem cell-based virotherapy is critical for optimal therapeu-
tic efficacy when applied with radiation and chemotherapy
for the treatment of glioblastoma [J]. Stem Cells Transl Med,
2013, 2(9): 655-666.
相似文献/References:
[1]陈正和 陈忠平.高级别胶质瘤的治疗现状及思考[J].中国临床神经外科杂志,2016,(06):350.[doi:10.13798/j.issn.1009-153X.2016.06.010]
[2]崔焕喜,柳 琛.多模态MRI、神经导航和超声在脑胶质瘤术中的应用[J].中国临床神经外科杂志,2016,(11):721.[doi:10.13798/j.issn.1009-153X.2016.11.027]
[3]闫 珊 徐善才.多学科护理照顾模式对脑胶质瘤术后病人自我护理能力的影响[J].中国临床神经外科杂志,2017,(05):352.[doi:10.13798/j.issn.1009-153X.2017.05.026]
YAN Shan,XU Shan-cai..Effects of multi-subjects nursing care model on self-care ability in patients with brain glioma after operation[J].,2017,(11):352.[doi:10.13798/j.issn.1009-153X.2017.05.026]
[4]罗似亮 夏之柏.脑胶质瘤病人脑脊液Midkine表达的临床意义[J].中国临床神经外科杂志,2017,(06):416.[doi:10.13798/j.issn.1009-153X.2017.06.017]
LUO Si-liang,XIA Zhi-bo..Clinical meanings of midkine expression in cerebrospinal fluid of patients with gliomas[J].,2017,(11):416.[doi:10.13798/j.issn.1009-153X.2017.06.017]
[5]呼铁民 褚会松 田 甜 王昆鹏 杨国军 杨立军 王维兴.脑胶质瘤ADAM17与EGFR的表达及临床意义[J].中国临床神经外科杂志,2017,(08):557.[doi:10.13798/j.issn.1009-153X.2017.08.012]
HU Tie-min,CHU Hui-song,TIAN Tian,et al.Expressions of ADAM17 and EGFR in gliomas tissues and their clinical meanings[J].,2017,(11):557.[doi:10.13798/j.issn.1009-153X.2017.08.012]
[6]高剑峰 姚庆和 李晓辉 龙宇波 陈振波.脑胶质瘤miR-9、PPARγ表达水平及临床意义[J].中国临床神经外科杂志,2018,(01):17.[doi:10.13798/j.issn.1009-153X.2018.01.006]
GAO Jian-feng,YAO Qing-he,LI Xiao-hui,et al.Expressions of miR-9 and PPARγ in human brain gliomas and their clinical meanings[J].,2018,(11):17.[doi:10.13798/j.issn.1009-153X.2018.01.006]
[7]刘 靖 吴立权 黄书岚.聚焦解决模式对脑胶质瘤术后病人自我管理效能感及生命意义的影响[J].中国临床神经外科杂志,2018,(03):208.[doi:10.13798/j.issn.1009-153X.2018.03.025]
LIU Jing,WU Li-quan,HUANG Shu-lan..Effects of solution focused intervention on self-management efficacy and meanings of life in the patients with gliomas after surgery[J].,2018,(11):208.[doi:10.13798/j.issn.1009-153X.2018.03.025]
[8]刘 炎 杭春华.脑胶质瘤卒中误诊为脑动静脉畸形并出血1例[J].中国临床神经外科杂志,2018,(06):448.[doi:10.13798/j.issn.1009-153X.2018.06.025]
[9]刘东明 胡新华 刘 永 陈 玖 刘宏毅.脑胶质瘤病人静息态默认模式网络研究进展[J].中国临床神经外科杂志,2018,(12):821.[doi:10.13798/j.issn.1009-153X.2018.12.022]
[10]张水仙 刘 丹 李 飞 胡 荣 冯 华.脑胶质瘤的循环生物标志物研究进展[J].中国临床神经外科杂志,2018,(12):824.[doi:10.13798/j.issn.1009-153X.2018.12.023]
[11]付 锴 江普查 宫 睿 王 伟.表达VASH1基因的人脑胶质瘤U-87MG细胞对化疗药物敏感性的变化[J].中国临床神经外科杂志,2016,(01):34.[doi:10.13798/j.issn.1009-153X.2016.01.012]
FU Kai,JIANG Pu-cha,GONG Rui,et al.Effect of lentiviral vector-mediated VASH1 gene on chemosensitivity of human glioma U-87MG cells[J].,2016,(11):34.[doi:10.13798/j.issn.1009-153X.2016.01.012]